Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial

M. Raps*, F. Rosendaal, B. Ballieux, J. Rosing, S. Thomassen, F. Helmerhorst, H. Van Vliet

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)855-861
JournalJournal of Thrombosis and Haemostasis
Issue number5
Publication statusPublished - May 2013


  • activated protein C resistance
  • natural estrogen
  • oral contraceptives
  • sex hormone binding globulin
  • thrombotic risk

Cite this